Brain Cancer Trial: Patient Sees Tumour Vanish – NHS Study
Groundbreaking Immunotherapy Trial Offers New Hope for Glioblastoma Patients
Table of Contents
A pioneering clinical trial, inspired by the legacy of a late campaigner, is offering a glimmer of hope for patients diagnosed with glioblastoma, one of the most aggressive forms of brain cancer. The new trial, dubbed “Margaret’s Trial,” focuses on boosting the patient’s immune system with immunotherapy before other treatments, a novel approach that has already shown promising results in early cases.
A Personal Battle Fuels a Wider Campaign
The story behind Margaret’s Trial is deeply personal.Dame Siobhain McDonagh MP spearheaded a fundraising campaign that successfully raised over £1 million to fund this crucial research. Her motivation stemmed from her sister, Baroness Margaret McDonagh, who tragically died from glioblastoma in 2023.
“My beloved sister Margaret was appalled to discover that there had been no advances in brain cancer treatment for decades when she was diagnosed with glioblastoma,” Dame Siobhain explained. “Changing this was Margaret’s final campaign and one that I have continued in her memory. I am so grateful to the many people who knew and respected Margaret who have come together and helped to raise funds and campaign for this new trial that we are calling margaret’s Trial.”
Early Successes and a New Approach
The trial’s innovative strategy involves administering immunotherapy to patients when they are still fit and well enough to tolerate it, aiming to prime their immune system to fight the cancer more effectively. This approach has already yielded encouraging outcomes for individuals like Ben Trotman.
Mr trotman, who was diagnosed with glioblastoma, received immunotherapy treatment as part of an earlier trial. This treatment, coupled with subsequent standard therapies like radiotherapy and chemotherapy, has kept his tumour at bay.”We hope that the immunotherapy and follow-up treatment Ben has had will hold his tumour at bay – and it has so far, which we are delighted to see,” said Mrs Trotman, reflecting on the initial shock of her husband’s diagnosis. “Getting this diagnosis was the most traumatic experience. We were grappling with the fact that Ben had gone from being apparently perfectly healthy to having months to live. Had we not met Dr Mulholland,that would have been it for us. We felt we had a lucky break in an or else devastating situation.”
Mr Trotman, who has since married and welcomed a daughter, continues to have clear quarterly scans. “We obviously don’t know what the future holds but having had the immunotherapy treatment and getting these encouraging scan results has given Emily and I a bit of hope,” he shared. “We are focused on rebuilding the life we thought we had lost and enjoying being parents.”
Expert Insights and Future Aspirations
Dr Paul Mulholland, a key figure in this research, expressed his gratitude for the campaign’s success. “When I met Margaret she said to me ‘what can I do to support you to cure this disease?’,” he recalled. “I am incredibly grateful to her and to Siobhain whose campaigning and fundraising in her sister’s memory has led to this new clinical trial opening for patients with this most aggressive form of brain cancer that has such a poor prognosis, with most patients surviving just nine months after diagnosis.”
Dr Mulholland elaborated on the trial’s core principle: “the crucial element of this trial is that patients will have their immune system boosted by the drug before they have any other treatment, when they are fit and well enough to tolerate the immunotherapy. We’re taking everything we have learned from previous trials into this new study and we are already planning follow-on trials. My aim is to find a cure for glioblastoma.”
Support and next steps
The National Brain Appeal is actively supporting Dr Mulholland’s research by funding two vital posts.Treatment for the Win-Glio trial will be administered at the NIHR UCLH’s Clinical Research Facility and the National Hospital for Neurology and Neurosurgery.Patients interested in participating in the new Win-Glio trial are encouraged to discuss the possibility with their consultant. This initiative represents a meaningful step forward in the fight against glioblastoma, driven by personal loss and a collective determination to advance treatment options.